The Simultaneous Separation and Determination of Six Flavonoids And

Total Page:16

File Type:pdf, Size:1020Kb

The Simultaneous Separation and Determination of Six Flavonoids And Journal of Chromatography B, 856 (2007) 222–228 The simultaneous separation and determination of six flavonoids and troxerutin in rat urine and chicken plasma by reversed-phase high-performance liquid chromatography with ultraviolet–visible detection Gong-Jun Yang a,∗, Ping Liu a, Xi-Long Qu a, Min-Juan Xu b, Qi-Shu Qu a, Cheng-Yin Wang a, Xiao-Ya Hu a, Zhi-Yue Wang b,∗ a College of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, 225002, PR China b College of Animal Science and Technology, Yangzhou University, Yangzhou 225002, PR China Received 31 January 2007; accepted 5 June 2007 Available online 12 June 2007 Abstract The method of high-performance liquid chromatography (HPLC) with UV–vis detection was used and validated for the simultaneous determi- nation of six flavonoids (puerarin, rutin, morin, luteolin, quercetin, kaempferol) and troxerutin in rat urine and chicken plasma. Chromatographic separation was performed using a VP-ODS column (150 mm × 4.6 mm, 5.0 ␮m) maintained at 35.0 ◦C. The mobile phase was a mixture of water, methanol and acetic acid (57:43:1, v/v/v, pH 3.0) at the flow rate of 0.8 mL/min. Six flavonoids and troxerutin were analyzed simultaneously with good separation. On optimum conditions, calibration curves were found to be linear with the ranges of 0.10–70.00 ␮g/mL (puerarin, rutin, morin, luteolin, quercetin, kaempferol) and 0.50–350.00 ␮g/mL (troxerutin). The detection limits were 0.010–0.050 ␮g/mL. The method was validated for accuracy and precision, and it was successfully applied to determine drug concentrations in rat urine and chicken plasma samples from rat and chicken that had been orally administered with six flavonoids and troxerutin. © 2007 Elsevier B.V. All rights reserved. Keywords: Flavonoids; Troxerutin; Reversed-phase high-performance liquid chromatography; Rat urine; Chicken plasma 1. Introduction one or more points in the cell cycle, inhibition of DNA synthe- sis, and modulation of signal transduction pathways by altered Flavonoids are a large family of over 4000 ubiquitous sec- expression of key enzymes such as cyclooxygenases and protein ondary plant metabolites, which can be further divided into kinases. Many experimental approaches have been used in these five subclasses including flavonols, flavones, anthocyanins, cat- investigations, including use of cell lines, whole animals and, echins and flavonones [1]. Flavonoids have anti-inflammatory, in a few instances, human cancer patients [4]. For example, in anti-carcinogenic and other beneficial properties and are widely Turkey, the resin which was collected from branches of P. tere- distributed in medicinal plants, fruit juices, teas and health bev- binthus ssp. terebinthus was used as an antiseptic for bronchitis erage resulting in high human consumption [2,3]. Now a large and other respiratory and urinary system diseases because of a number of literatures have been devoted to studies describ- lot of flavonoids in resin [5]. Troxerutin shows a marked affinity ing the potential anticancer activities of flavonoids. In many for the venous wall, it may act to improve capillary function, instances, these effects can be attributed to plausible biochemi- reduce capillary fragility and reduce abnormal leakage. Appli- cal mechanisms including enhanced apoptosis, growth arrest at cations also exist for reducing the occurrence of night cramps and other circulatory problems. Its common usage is mainly in ∗ the treatment of varicose veins and haemorrhoids [6]. Corresponding authors. Tel.: +86 514 7975590x9217/7979045; Up to now, analysis of flavonoids has been accomplished fax: +86 514 7975244. E-mail addresses: [email protected], [email protected] by thin-layer chromatography [7–9], gas chromatography (G.-J. Yang), [email protected] (Z.-Y. Wang). [10,11], capillary electrophoresis [12–17], electrochemical 1570-0232/$ – see front matter © 2007 Elsevier B.V. All rights reserved. doi:10.1016/j.jchromb.2007.06.002 G.-J. Yang et al. / J. Chromatogr. B 856 (2007) 222–228 223 mensuration [18–20], high-performance liquid chromatography 2. Experimental (HPLC) [1,2,5,6,21–30]. Especially, HPLC was widely used to separate and analyse flavonoids. For example, Wang et al. [26] 2.1. Chemical and reagents reported the determination of flavonols (such as: myricetin, quercetin, kaempferol ) in green and black tea leaves and green Flavonoid standards (see Scheme 1), including rutin, morin, tea infusions by following HPLC method with diode array luteolin, quercetin and kaempferol, which were purchased from detection, and the mobile phase consisted of 30% acetonitrile Sigma–Aldrich. Puerarin and troxerutin (see Scheme 1)was in 0.025 M KH2PO4 buffer solution (v/v), which was adjusted kindly gifted by Yangzhou Institute of Drug Control. Ultrapure to pH 2.5 by 6.0 M HCl. Fang et al. [27] adopted the elu- water at 18.3 M resistance, used for HPLC mobile phase, was tion program to determine quercetin, kaempferol, myricetin, prepared using a Nanopure (New Haven, CT, USA) filtration rhamnetin, isorhamnetin, quercetrin, rutin, morin, galangin, system. HPLC-grade methanol was purchased from Fisher fisetin, apigenin and luteolin in red wine by reversed-phase (Nepean, ON, Canada). All other chemicals were of analytical high-performance liquid chromatography (RP-HPLC) with grade. UV–visible detector. However, to the best of our knowledge, there were few literatures to report the separation of troxerutin 2.2. Chromatography and puerarin or quercetin by RP-HPLC in previous studies. Especially, there was no way to simultaneously separate six The HPLC (Shimadzu, Kyoto, Japan) instrument was flavonoids and troxerutin in rat urine and chicken plasma. equipped with a model series LC-10 ADVP pump, DGU-12 In this paper, the main objective of this study was to develop A degasser, SCL-10 AVP system controller, Rheodyne 7725 a reversed-phase high-performance liquid chromatographic injector with a 20 ␮L loop and a SPD-10AVP UV–Vis detector. method for the simultaneous separation and determination of Separation and determination have been done on a VP-ODS six flavonoids and troxerutin in rat urine and chicken plasma column (5 ␮m particle size, 150 mm × 4.6 mm i.d. Shimadzu, after the oral administration. The proposed HPLC method was Kyoto, Japan). Data acquisition was performed on class-VP accurate, simple and efficient for simultaneous separation and software. The column was thermostatically controlled at 35 ◦C. determination of six flavonoids and troxerutin, and it can be The mobile phase was prepared by mixing water, methanol and applied to determine their content in rat urine and chicken plasma acetic acid in a ratio of 57:43:1 (v/v/v, pH 3.0) at a flow rate samples with satisfactory results. of 0.8 mL/min. The mobile phase was filtered using 0.22 ␮m Scheme 1. Molecular structures of the analytes. 224 G.-J. Yang et al. / J. Chromatogr. B 856 (2007) 222–228 membrane filter (Millipore, Milford, MA) and degassed by calibrator stock solutions, quality control stock solutions, and vacuum prior to use. The detection was set at a wavelength of unknown samples were thawed and vortexed for 30 s. Calibra- 254 nm. An aliquot of 10 ␮L injections were made for each tor and quality control solutions were freshly prepared by adding concentration under the specified chromatographic conditions. 50 ␮L of each stock solution to 450 ␮L of blank chicken plasma, then 1.0 mL of methanol was added. The mixture was vortexed 2.3. Preparation of reference standard solutions for 1.0 min, and centrifugated at 12000 rpm for 10.0 min. Five- hundred microliters of each ultrafiltrate was transferred and Individual standard stock solution of six flaovonids and trox- 10 ␮L of them was injected for analysis. erutin was prepared at a concentration of 1.0 mg/mL in methanol. Standard solutions were diluted to obtain three different con- 2.5. Calibration centrations of six flavonoids (1.0, 5.0, and 20.0 ␮g/mL) and troxerutin (5.0, 25.0, and 100.0 ␮g/mL), and were stored at Calibration curves were produced by injecting prepared rat −20 ◦C. And then the concentrations were determined for 7, urine samples and prepared chicken plasma samples that were 18 and 30 days. Data were compared with results obtained from spiked with six flavonoids concentrations (0.10, 0.50, 1.00, 5.00, freshly prepared standard solution. The change of troxerutin con- 10.00, 30.00, 50.00, 70.00 ␮g/mL) and troxerutin concentrations centration was less than 2.3% after 7 days, 4.0% after 18 days, (0.50, 2.50, 5.00, 25.00, 50.00, 150.00, 250.00, 350.00 ␮g/mL). and the change of six flavonoids concentration was less than 5% An aliquot of 10 ␮L of the resulting solution was injected into for 30 days. HPLC system, and each concentration was analyzed for five times. After determining the peak area, calibration lines of peak 2.4. Sample preparation area versus analyte concentrations were plotted. 2.4.1. Sample preparation – rat urine 2.6. Recovery Six female Wistar rats (weighing 350 ± 10 g, Experimental Animal Research Center of Medicine College, Yangzhou Uni- The relative recovery in rat urine and chicken plasma versity, China) were housed in metabolic cages for collection samples were evaluated at three concentrations 1.00, 5.00 of urine. The rats were provided standard laboratory food and and 20.00 ␮g/mL for six flavonoids and 5.00, 25.00 and water. Before being administered 200 mg/kg of six flaovonids 100.00 ␮g/mL for troxerutin. The rat urine and chicken plasma and troxerutin, the rats were fasted for 24 h but with access to were processed as described under preparation of sample solu- water. Urine samples were collected for a period of 8 h.
Recommended publications
  • Antiplatelet Effects of Flavonoids Mediated by Inhibition of Arachidonic Acid Based Pathway
    76 Original Papers Antiplatelet Effects of Flavonoids Mediated by Inhibition of Arachidonic Acid Based Pathway Authors Jana Karlíčková1, Michal Říha2,Tomáš Filipský2, Kateřina Macáková1, Radomír Hrdina2,Přemysl Mladěnka2 Affiliations 1 Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic Key words Abstract able concentration. Contrarily, many flavonoids, l" aggregation ! particularly those possessing an isolated 7-hy- l" arachidonic acid Flavonoids, important components of human di- droxyl group and/or a 4′-hydroxyl group, acted l" cyclooxygenase et, have been claimed to possess a significant anti- as antagonists on thromboxane receptors. Inter- l" flavonoid platelet potential, in particular due to their effects estingly, the substitution of the free 7-hydroxyl l" platelet l" thromboxane on the arachidonic acid cascade. Due to variable group by glucose might not abolish the activity. and incomplete results, this study was aimed at In conclusion, the consumption of few flavonoids delivering a detailed analysis of the effects of 29 in a diet, particularly of the isoflavonoids geniste- structurally relevant, mainly natural flavonoids in and daidzein, may positively influence platelet on three consecutive steps of the arachidonic acid aggregation. cascade. Only the isoflavonoids genistein and daidzein were shown to possess a marked cyclooxygen- Abbreviations ase-1 inhibitory activity, which was higher than ! that of acetylsalicylic acid using the isolated ovine AA: arachidonic acid enzyme, and physiologically relevant, although ASA: acetylsalicylic acid lower than acetylsalicylic acid in human platelets.
    [Show full text]
  • Bioactivities of Phenolics by Focusing on Suppression of Chronic Diseases: a Review
    International Journal of Molecular Sciences Review Bioactivities of Phenolics by Focusing on Suppression of Chronic Diseases: A Review Fereidoon Shahidi * ID and JuDong Yeo Department of Biochemistry, Memorial University of Newfoundland, St. John’s, NL A1B 3X9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-709-864-8552 Received: 4 May 2018; Accepted: 23 May 2018; Published: 25 May 2018 Abstract: Phenolics, which are secondary metabolites of plants, exhibit remarkable bioactivities. In this contribution, we have focused on their protective effect against chronic diseases rather than their antioxidant activities, which have been widely discussed in the literature. A large body of epidemiological studies has proven the bioactivities of phenolics in both standard compounds and natural extracts: namely, anticancer, anti-inflammatory, and antibacterial activities as well as reducing diabetes, cardiovascular disease, and neurodegenerative disease. Phenolics also display anti-analgesic, anti-allergic, and anti-Alzheimer’s properties. Thus, this review provides crucial information for better understanding the bioactivities of phenolics in foods and fills a gap in the existing collective and overall knowledge in the field. Keywords: phenolics; bioactivity; phenolic acid; flavonoids; anticancer; anti-inflammatory activity; antibacterial activity 1. Introduction 1.1. Phenolics Phenolic compounds are secondary metabolites of plants. So far, more than 8000 phenolics have been found from natural sources and are classified into phenolic acids, flavonoids, stilbenes, coumarins, lignins, and tannins. Phenolics play a crucial role in plants by controlling their growth as an internal physiological regulator [1]. For instance, kaempferol, apigenin, and quercetin interact with plasma membrane proteins (receptors), in which they restrict the transfer of polar auxin compounds via the membrane, thus affecting plant growth [1].
    [Show full text]
  • Important Flavonoids and Their Role As a Therapeutic Agent
    molecules Review Important Flavonoids and Their Role as a Therapeutic Agent Asad Ullah 1 , Sidra Munir 1 , Syed Lal Badshah 1,* , Noreen Khan 1, Lubna Ghani 2, Benjamin Gabriel Poulson 3 , Abdul-Hamid Emwas 4 and Mariusz Jaremko 3,* 1 Department of Chemistry, Islamia College University Peshawar, Peshawar 25120, Pakistan; [email protected] (A.U.); [email protected] (S.M.); [email protected] (N.K.) 2 Department of Chemistry, The University of Azad Jammu and Kashmir, Muzaffarabad, Azad Kashmir 13230, Pakistan; [email protected] 3 Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia; [email protected] 4 Core Labs, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia; [email protected] * Correspondence: [email protected] (S.L.B.); [email protected] (M.J.) Received: 20 September 2020; Accepted: 1 November 2020; Published: 11 November 2020 Abstract: Flavonoids are phytochemical compounds present in many plants, fruits, vegetables, and leaves, with potential applications in medicinal chemistry. Flavonoids possess a number of medicinal benefits, including anticancer, antioxidant, anti-inflammatory, and antiviral properties. They also have neuroprotective and cardio-protective effects. These biological activities depend upon the type of flavonoid, its (possible) mode of action, and its bioavailability. These cost-effective medicinal components have significant biological activities, and their effectiveness has been proved for a variety of diseases. The most recent work is focused on their isolation, synthesis of their analogs, and their effects on human health using a variety of techniques and animal models.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Chronic Venous Insufficiency/CVI
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Chronic Venous Insufficiency/CVI Chemical Activity Count (+)-AROMOLINE 1 (+)-CATECHIN 5 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-PRAERUPTORUM-A 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-ACETOXYCOLLININ 1 (-)-APOGLAZIOVINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-EPICATECHIN 4 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 2 (-)-EPIGALLOCATECHIN-GALLATE 3 (-)-HYDROXYJASMONIC-ACID 1 (-)-N-(1'-DEOXY-1'-D-FRUCTOPYRANOSYL)-S-ALLYL-L-CYSTEINE-SULFOXIDE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 Chemical Activity Count 1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)-1,6-HEPTADIEN-3,5-DIONE 1 1,8-CINEOLE 1 1-(METHYLSULFINYL)-PROPYL-METHYL-DISULFIDE 1 1-ETHYL-BETA-CARBOLINE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-GINGEROL 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 14-ACETOXYCEDROL 1 14-O-ACETYL-ACOVENIDOSE-C 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 2,3,7-TRIHYDROXY-5-(3,4-DIHYDROXY-E-STYRYL)-6,7,8,9-TETRAHYDRO-5H-
    [Show full text]
  • Analysis of the Binding and Interaction Patterns of 100 Flavonoids with the Pneumococcal Virulent Protein Pneumolysin: an in Silico Virtual Screening Approach
    Available online a t www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (16):40-51 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 Analysis of the binding and interaction patterns of 100 flavonoids with the Pneumococcal virulent protein pneumolysin: An in silico virtual screening approach Udhaya Lavinya B., Manisha P., Sangeetha N., Premkumar N., Asha Devi S., Gunaseelan D. and Sabina E. P.* 1School of Biosciences and Technology, VIT University, Vellore - 632014, Tamilnadu, India 2Department of Computer Science, College of Computer Science & Information Systems, JAZAN University, JAZAN-82822-6694, Kingdom of Saudi Arabia. _____________________________________________________________________________________________ ABSTRACT Pneumococcal infection is one of the major causes of morbidity and mortality among children below 2 years of age in under-developed countries. Current study involves the screening and identification of potent inhibitors of the pneumococcal virulence factor pneumolysin. About 100 flavonoids were chosen from scientific literature and docked with pnuemolysin (PDB Id.: 4QQA) using Patch Dockprogram for molecular docking. The results obtained were analysed and the docked structures visualized using LigPlus software. It was found that flavonoids amurensin, diosmin, robinin, rutin, sophoroflavonoloside, spiraeoside and icariin had hydrogen bond interactions with the receptor protein pneumolysin (4QQA). Among others, robinin had the highest score (7710) revealing that it had the best geometrical fit to the receptor molecule forming 12 hydrogen bonds ranging from 0.8-3.3 Å. Keywords : Pneumococci, pneumolysin, flavonoids, antimicrobial, virtual screening _____________________________________________________________________________________________ INTRODUCTION Streptococcus pneumoniae is a gram positive pathogenic bacterium causing opportunistic infections that may be life-threating[1]. Pneumococcus is the causative agent of pneumonia and is the most common agent causing meningitis.
    [Show full text]
  • In Vitro Evaluation of Copper-Chelating Properties of Flavonoids
    RSC Advances View Article Online PAPER View Journal | View Issue In vitro evaluation of copper-chelating properties of flavonoids† Cite this: RSC Adv.,2014,4, 32628 a b a b ac Michal Rˇ´ıha, Jana Karl´ıckovˇ a,´ Toma´ˇs Filipsky,´ Kateˇrina Macakov´ a,´ Liliana Rocha, d e f b Paolo Bovicelli, Ilaria Proietti Silvestri, Luciano Saso, Ludekˇ Jahoda´ˇr, a a Radom´ır Hrdina and Pˇremysl Mladenkaˇ * Copper is an essential trace element involved in plenty of redox reactions in living systems, however, unbound copper ions cause damage to various biomolecules via excessive generation of reactive oxygen species. Flavonoids, ubiquitous plant secondary metabolites, possess complex effects on human health and chelation of transient metal ions is one of their proposed mechanisms of action. In this in vitro study, 26 flavonoids from various subclasses were screened for their interactions with both copper oxidation states at four (patho)physiologically relevant pH conditions (4.5, 5.5, 6.8 and 7.5) by two spectrophotometric approaches and compared with the clinically used copper chelator trientine. In a slightly competitive environment, the majority of flavonoids were able to chelate cupric ions, however, Creative Commons Attribution 3.0 Unported Licence. under more competitive conditions, only flavones and flavonols were able to chelate both cupric and cuprous ions. Apparently, the 2,3-double bond was essential for stable copper chelation. The most efficient copper chelation sites were the 3-hydroxy-4-keto group in flavonols and the 5,6,7-trihydroxyl group in flavones. On the other hand, the 30,40-dihydroxyl group was associated only with a weak Received 15th May 2014 activity.
    [Show full text]
  • Product# Description Qty Price Product# Description Qty Price
    349 Product# Description Qty Price Product# Description Qty Price ASB-00017171-005 QUERCITRIN 5mg $ ASB-00030615-005 RABDOSIA AERIAL PARTS RBRM 5g $ ASB-00017171-010 10mg $ Grade : RBRM ASB-00017171-025 25mg $ FW : 0 For : Rabdosia rubescens Grade : P From : Aerial parts CAS# : [522-12-3] Other Names : Rabdosia rubescens Chemical Formula : C21H20O11 FW : 448.38 MERCK Index# : 11,8047 Rabdosia rubescens Long-Term Storage : RT Please See RABDOSIA AERIAL PARTS RBRM QUERCUS ALBA L. [FAGACEAE] Raffinose Please See RAFFINOSE, D-(+)-(RG) Please See WHITE OAK BARK VBRM 1g $ Quertine ASB-00018010-001 RAFFINOSE, D-(+)- Grade : RG Please See QUERCETIN(AHP) CAS# : [17629-30-0] Quertine Chemical Formula : C18H32O16.5H2O FW : 504.45 Please See QUERCETIN(SH) MERCK Index# : 11,8120 Long-Term Storage : RT Quertine Other Names : Raffinose Please See QUERCETIN(RG) Quindine Rahmnoxanthin Please See QUINIDINE(RG) Please See FRANGULIN A(RG) Quinic Acid Rahmnoxanthin Please See QUINIC ACID(RG) Please See FRANGULIN B(RG) ASB-00017176-100 QUINIC ACID 100mg $ Rahmnoxanthin ASB-00017176-250 250mg $ Please See FRANGULIN A(P) Grade : P (14R)-7-ALPHA,20-EPOXY-1-ALPHA,6-BETA,7,14-TETRAHYDROXYKAUR-16-EN-15-ONE CAS# : [77-95-2] Chemical Formula : C7H12O6 Please See RUBESCENSIN A(RG) FW : 192.18 MP : 170 C Rapanone Long-Term Storage : RT Please See RAPANONE(RG) ASB-00018020-005 RAPANONE 5mg $ ASB-00017175-001 QUINIC ACID 1g $ Grade : RG Grade : RG CAS# : [573-40-0] CAS# : [77-95-2] Chemical Formula : C19H30O4 Chemical Formula : C7H12O6 FW : 322.46 FW : 192.18 Other Names
    [Show full text]
  • 121 Role of Flavonoid Troxerutin on Blood Pressure, Oxidative Stress
    [Frontiers In Bioscience, Elite, 11, 121-129, Jan 1, 2019] Role of flavonoid troxerutin on blood pressure, oxidative stress and regulation of lipid metabolism Boobalan Raja1, Dhanasekaran Saranya1, Rajendran Prabhu1 1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Materials and methods 3.1. Animals and chemicals 3.2. L-NAME induced hypertensive animal model and troxerutin treatment 3.3. Experimental protocol 3.4. Preparation of tissue homogenates 3.5. Blood pressure measurement 3.6. Lipid peroxidation products and antioxidants 3.7. Tissue lipid level 3.8. Hepatic marker enzymes and renal function markers 3.9. Statistical analysis 4. Results 4.1. Effect of TX on systolic blood pressure 4.2. Effect of TX on lipid peroxidation products 4.3. Effect of TX on antioxidant level 4.4. Effect of TX on lipid level 4.5. Effect of TX on hepatic and renal function markers 5. Discussion 6. Acknowledgements 7. References 1. ABSTRACT These results suggest that TX has enough potential to attenuate hypertension, oxidative stress and The objective of the present study was to dyslipidemia in L-NAME induced hypertensive rats. investigate the effects of troxerutin (TX) on Nω-nitro-L- arginine methyl ester hydrochloride (L-NAME) induced 2. INTRODUCTION hypertension in male albino Wistar rats. L-NAME (40mg/kg body weight (bw)) administration caused a Hypertension is the most common sustained increase in systolic blood pressure (SBP), cardiovascular disorder both in developed and in levels of thiobarbituric acid reactive substances developing countries and has emerged as one of the (TBARS), lipid hydroperoxides (LOOH), tissue lipids major causes of mortality and morbidity worldwide.
    [Show full text]
  • Estonian Statistics on Medicines 2013 1/44
    Estonian Statistics on Medicines 2013 DDD/1000/ ATC code ATC group / INN (rout of admin.) Quantity sold Unit DDD Unit day A ALIMENTARY TRACT AND METABOLISM 146,8152 A01 STOMATOLOGICAL PREPARATIONS 0,0760 A01A STOMATOLOGICAL PREPARATIONS 0,0760 A01AB Antiinfectives and antiseptics for local oral treatment 0,0760 A01AB09 Miconazole(O) 7139,2 g 0,2 g 0,0760 A01AB12 Hexetidine(O) 1541120 ml A01AB81 Neomycin+Benzocaine(C) 23900 pieces A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+Thymol(dental) 2639 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+Cetylpyridinium chloride(gingival) 179340 g A01AD81 Lidocaine+Cetrimide(O) 23565 g A01AD82 Choline salicylate(O) 824240 pieces A01AD83 Lidocaine+Chamomille extract(O) 317140 g A01AD86 Lidocaine+Eugenol(gingival) 1128 g A02 DRUGS FOR ACID RELATED DISORDERS 35,6598 A02A ANTACIDS 0,9596 Combinations and complexes of aluminium, calcium and A02AD 0,9596 magnesium compounds A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 591680 pieces 10 pieces 0,1261 A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 1998558 ml 50 ml 0,0852 A02AD82 Aluminium aminoacetate+Magnesium oxide(O) 463540 pieces 10 pieces 0,0988 A02AD83 Calcium carbonate+Magnesium carbonate(O) 3049560 pieces 10 pieces 0,6497 A02AF Antacids with antiflatulents Aluminium hydroxide+Magnesium A02AF80 1000790 ml hydroxide+Simeticone(O) DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 34,7001 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 3,5364 A02BA02 Ranitidine(O) 494352,3 g 0,3 g 3,5106 A02BA02 Ranitidine(P)
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Varicose Veins
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Varicose Veins Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-CATECHIN 7 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 2 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PRAERUPTORUM-A 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ACETOXYCOLLININ 1 (-)-ALPHA-BISABOLOL 2 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DICENTRINE 1 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 3 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 2 (-)-EPIGALLOCATECHIN-GALLATE 3 (-)-HYDROXYJASMONIC-ACID 1 Chemical Activity Count (-)-N-(1'-DEOXY-1'-D-FRUCTOPYRANOSYL)-S-ALLYL-L-CYSTEINE-SULFOXIDE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 2 (15:1)-CARDANOL 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 2 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)-1,6-HEPTADIEN-3,5-DIONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 3 1-(METHYLSULFINYL)-PROPYL-METHYL-DISULFIDE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 2 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 12,118-BINARINGIN 1 12-ACETYLDEHYDROLUCICULINE
    [Show full text]
  • 1 Revealing SARS-Cov-2 Functional Druggability Through Multi-Target
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 11 May 2020 doi:10.20944/preprints202005.0199.v1 Revealing SARS-CoV-2 Functional Druggability Through Multi-Target Cadd Screening of Repurposable Drugs Yash Gupta1,2, Dawid Maciorowski1,3, Raman Mathur1, Catherine M Pearce1, David J. IIc1,3, Hamza Husein1,3, Ajay Bharti4, Daniel P. Becker3, Brijesh Rathi2,5, Steven B Bradfute6, Ravi Durvasula1,2, Prakasha Kempaiah1,2* 1 Loyola University Chicago Stritch School of Medicine, Chicago, IL, 60153, USA; 2 Department of Medicine, Loyola University Medical Center, Chicago, IL, 60153, USA; 3 Loyola University Chicago, Chicago, IL, USA; 4 Division of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, 92093, USA, 5 Laboratory for Translational Chemistry and Drug Discovery, Hansraj College, University of Delhi, India; 6 Center for Global Health, Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA. Number of Tables: 10; Number of Figures: 16 ABSTRACT: The emergence of SARS/MERS drug resistant COVID-19 with high transmission and mortality has recently been declared a deadly pandemic causing economic chaos and significant health problems. Like all coronaviruses, SARS-CoV-2 is a large virus that has many druggable components within its proteome. In this study, we focused on repurposing approved and investigational drugs by identifying potential drugs that are predicted to effectively inhibit critical enzymes within SARS-CoV-2. We shortlisted seven target proteins with enzymatic activities known to be essential at different stages of the virus life cycle. For virtual screening, the energy minimization of a crystal structure or modeled protein was carried out using Protein Preparation Wizard (Schrödinger LLC, 2020-1).
    [Show full text]
  • Flavonoid Compounds Benzquercin (R!NN)
    Gilenya; Norw. : Gilenya; Spain: Gilenya; Swed.: Gilenya; reintroduction of fingolimod if treatment has been stopped Oxerutins (BAN) for more than 2 weeks, and the precautions for re�initiating Switz.: Gilenya; Turk.: Gilenya; UK: Gilenya; USA: Gilenya. treatment outlined above should be followed. Hidroxileti!rut6sidos; Hydroxyethyir�tosides; Oxerutlnas: Fingolimod may increase the risk of developing 0Kcepynmot infections due to the reduction in peripheral lymphocyte Flavonoid Compounds Description. Oxerutins consist of a mixture of 5 different count (see Uses and Administration, p. 2504.3), and 0-(P-hydroxyethyl)rutosides, not less than 45% of which is mo f!avonoides; 8iofiavonoids; Flavonoides: Vitarnin treatment should not be started in patients without a recent P troxerutin (trihydroxyethylrutoside, below), but which also Substances; Vitamlnas full blood count taken within the previous 6 months. P; <DnqBOHOMj:jol. includes monohydroxyethylrutoside, dihydroxyethylruto­ Fingolimod should not be started in patients with active side, and tetrahydroxyethylrutoside. acute or chronic infections. Patients should be monitored Benzquercin (r!NN) for signs and symptoms of infection during treatment and Quercetin for 2 months after treatment has stopped. Stopping Benzqueccina; Benzquercine; Benzquercinum; 6et!3KB€PLi�H. fingolimod should be considered if a patient develops a 3,3',4';5,7-Pentakis(benzyloxy) flavone. Quercetina; Keep:.;erv.H: 3,3',4',5,7-Pentahydroxyftavone. serious infection during treatment, and then the risks versus C,oKNJ0,=752.9 2-(3,4-Dihydroxyphenyl)-3,5,7-trihy droxy�4H- 1 -benzopyran- benefits reassessed before treatment is resumed. 4--one, Patients without a history of chickenpox or who have not C4$ - 13157-90-9. received varicella Mzoster vaccination should be tested for UN/! - 499L710 905.
    [Show full text]